This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
S&P 500 to Hit At Least 7,500-Mark in 2026? ETFs in Focus
by Sanghamitra Saha
Wall Street sees the S&P 500 hitting 7,500-8,000 in 2026 on AI-fueled earnings growth and rate-cut hopes. ETFs like VOO, IVV and SPY stand to benefit.
ETFs to Benefit From Rate Cut Bets and Upbeat Forecasts
by Yashwardhan Jain
ETFs to watch as Wall Street turns upbeat, with bullish forecasts putting the S&P 500 on track for 8,000 by 2026.
Be Thankful to These ETFs This Year
by Sanghamitra Saha
Be thankful for this year's resilient ETFs -- BWET, LITP, PINK and CANC -- which shined despite volatility, tariffs, AI worries and Fed shifts.
Is Dow Jones ETF Better-Placed Than S&P 500 & Nasdaq?
by Sanghamitra Saha
The Dow Jones ETF DIA may outperform SPY and QQQ as rate-cut hopes rise, tech volatility lingers and defensive sectors strengthen.
Pre-markets Try Again, Begin Session in the Green
by Mark Vickery
We were in a similar position yesterday, only to see the strong open to the stock market slide away into negative territory and stay there.
Inside the Recent Strength in Biotech ETFs
by Sanghamitra Saha
Biotech strength is back, with IBB, PBE, FBT, CANC and HELX climbing as cheaper valuations, rate-cut hopes, FDA approvals and strong deal activity fuel biotech gains.
The Zacks Analyst Blog Highlights MS, VOO, SPY, IVV, SPYM, RSP, EQ and EQWL
by Zacks Equity Research
MS sees U.S. equities outpacing global markets into 2026, lifting its S&P 500 outlook and spotlighting ETFs poised to benefit.
U.S. Outperformance in Sight? ETFs to Play Morgan Stanley's Forecast
by Yashwardhan Jain
Morgan Stanley sees U.S. equities outpacing global markets into 2026, with AI-driven gains and small-cap strength supporting its upbeat S&P 500 outlook.
Build Buffett's Berkshire-Like Portfolio With These ETFs
by Sanghamitra Saha
Build a Buffett-style portfolio with ETFs. Berkshire's latest moves spotlight GOOGL, staples, insurance picks and ETFs like GXPC, FCOM, IYK, PBJ, IAK and KBWP.
What's Behind Silver's Explosive Gains?
by Neena Mishra
We spotlight silver ETFs that have surged this year
Buffett's Investing Lessons: What They Mean for ETF Investors
by Sanghamitra Saha
Buffett's final lessons guide ETF investors toward discipline, cash strength and quality picks like SPY, ITOT, VTV and MINT.
Cisco Surges on Earnings Beat & Upbeat Guidance: ETFs in Focus
by Sanghamitra Saha
Cisco jumped on strong earnings and upbeat guidance, driven by AI demand. Investors can explore ETFs like IYZ, CIBR, and HACK for exposure.
Should SPDR S&P 500 ETF (SPY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPY
Is the S&P 500 Poised for a New High? ETFs to Consider
by Yashwardhan Jain
UBS forecasts the S&P 500 to hit 7,500 next year, fueled by tech-led earnings growth and rising investor optimism around AI-driven gains.
Senate's Deal Signals Potential End to US Govt. Shutdown: Top ETFs to Buy
by Aparajita Dutta
A bipartisan Senate deal signals an end to the U.S. government shutdown, sparking investor interest in ETFs like XLV and SPY.
U.S. Equities Lag International in 2025: 5 Top ETF Performers
by Sanghamitra Saha
International ETFs like FDT, IDV, FDTS, EFAS & FLEU soared as investors pivot from pricey and uncertain policy-driven U.S. markets to undervalued international plays.
Zacks Investment Ideas feature highlights S&P 500
by Zacks Equity Research
S&P 500 have been highlighted in this Investment Ideas article.
November Pullback Underway: Here's What to Know
by Bryan Hayes
The latest bearish headlines point to hefty AI valuations. But here's why this bull market likely still has some legs.
Fearing AI Valuation Concerns? Tap 3 High-Dividend ETFs
by Sanghamitra Saha
Fearing AI valuation risks? Seek stability in dividends. ETFs like SDEM, DVYE & LVHI are shining with strong yields and recent gains.
Worried About an AI Bubble? Look to Surging International Stocks
by Neena Mishra
We spotlight three international ETFs that are outperforming the S&P 500 by a wide margin.
Biotech ETFs Hovering Around a 52-Week: Here's Why
by Sanghamitra Saha
Biotech is back! Regulatory tailwinds, cheaper valuations, and Fed cut hopes are boosting ETFs like XBI and IBB. Is the rebound just starting?
Russell 2000 Beats S&P 500 Over Past 6 Months: ETFs in Focus
by Sanghamitra Saha
Small caps rebounded lately. ETFs like IWM, FESM, VTWO & more outpaced SPY in 6 months as rate-cut hopes and easing tariffs fueled momentum.
Bank ETFs in Red Over the Past Month: Pain or Gain Ahead? (Revised)
by Sanghamitra Saha
Bank ETFs like IYG, IYF, KBWB, XLF and VFH dip on credit jitters. Are gains ahead as Q3 earnings & a steepening yield curve offer hope?
Bank ETFs in Red Over the Past Month: Pain or Gain Ahead?
by Sanghamitra Saha
Bank ETFs like IYG, IYF, KBWB, XLF and VFH dip on credit jitters. Are gains ahead as Q3 earnings & a steepening yield curve offer hope?
Biotech ETFs Bounce Back in 2025: Here's Why
by Sanghamitra Saha
Biotech ETFs rally. IBB, ARKG, SBIO, BBC, CANC and BBP soar as Fed rate cut optimism, FDA approvals, deals and cheaper valuations drive the space in 2025.